Quest Diagnostics Incorporated (DGX)
NYSE • Healthcare
November 12, 2026 at 17:17 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Quest Diagnostics Incorporated keeps $10 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Feb 9
in 89 daysQ1 2027% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Quest Diagnostics topped consensus on both revenue and earnings in the third fiscal quarter of 2026, based on preliminary results reported October 22, 2026, with revenue up 10.0% to about $3.1 billion and adjusted EPS of $3.00 topping the $2.87 estimate (+4.5%). On the top line, revenue of $3.097 billion topped the $3.052 billion estimate (+1.5%) as the quarter reflected continued demand across its diagnostic information services footprint, including routine and advanced clinical testing and anatomic pathology. Profitability came through at a gross margin of ~34% and an operating margin of roughly 16%, translating to about $312.0 million of net income, up 27.3% from roughly $245.0 million a year ago. Cash generation was positive, with operating cash flow of about $740.0 million, and Quest returned capital through roughly $150.0 million of share repurchases and about $95.0 million in dividends during the period. For the next period, consensus calls for EPS of $2.68 on revenue of $3.034 billion.
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (NYSE: DGX) provides diagnostic information services, risk assessment services, and healthcare information technology in the medical diagnostics and research business. The company generated $11.0 billion of revenue in FY2025. Its work spans routine and advanced clinical testing, anatomic pathology, insurance-focused assessments, and software used by healthcare organizations and clinicians.
Today's Snapshot
DGX opened 1.2% above yesterday's close, while its sector was flat. Early in the session, DGX is within 0.3% of its 52-week high of 262.00. Quest Diagnostics paid $13 million to settle kickback claims.
Trading Volume
Below 10d avg (841.3K)
96.9K
vs S&P 500 Today
Outperforming Market
+1.31%
Updated: November 12, 2026 at 15:39 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$217.01 - $255.25Buy
- RSI (14)69.94Neutral
- Stochastic %K (14, 3, 3)93.94Sell
- MACD Level (12, 26)6.00Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.